i.e. the toxic activity, the G,, receptor-binding capacity and the antigenic (antibody-fixing) properties, have been studied quantitatively using microgram amounts or less of toxin protein.
Modi$cation of cholera toxin Table I * Unless specified incubation was performed at 23 "C for I hour.
f The reagent was first dissolved in the organic solvent and then added to the buffered toxin solution.
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of 30 pg of toxin were given subcutaneously at intervals of 3 weeks; the blood was collected two weeks after the last injection. The serum contained precipitating antibodies against the L as well as the H subunits of the toxin as shown by double diffusion-in-gel analyses . Ganglioside G,,. The ganglioside G,, was purified from human brain by L. Svennerholm, Goteborg, Sweden (Svennerholm, 1972) .
Protein mod$cation. Table I presents the amino acid ' specific' protein modification reagents used, their sources, and the incubation conditions employed for toxin treatment. A 1 2 p~ ( I mg/ml) solution of cholera toxin was prepared by dilution in distilled water and was further diluted I : 10 in the appropriate buffer containing the protein-modifying reagent. The mixture, total volume 50 pl, was incubated as specified for each reagent ( Table I) . The standard reagent concentration was 1 0 PM, but if an effect on any of the toxin properties studied was observed then additional toxin derivatives were prepared using other reagent concentrations. The reaction was stopped and the reactants separated by filtration through a 5 x 70 mm Sephadex G-15 column. The protein fraction was collected and diluted in TG buffer to a final concentration of 0.024 pM (2 pg/ml) cholera protein. It was divided into small portions which were stored at -20 "C until tested at multiple concentrations. The control test for each reaction consisted of incubating toxin under the appropriate conditions but without the modifying reagent. The control was gel-filtered, diluted and stored like the test preparation.
Lyophilized V. choZerae culture filtrate was dissolved to 200 mg/ml in distilled water, dialysed against 0.05 M-NaCI and concentrated to give a solution containing 20 mg bacterial protein/ml. This preparation, which contained approximately 0.2 mg cholera toxin/ml, was treated with chemical reagents as described for the purified toxin.
Enzymic treatment. Three enzymes (Sigma) were used : leucine aminopeptidase type I11 (86 u/mg) at a final concentration of 0.67 mg/ml, carboxypeptidase A DFP (47 u/mg) at 7 mg/ml, and trypsin type I11 (100 u/mg) at I mg/ml. Each enzyme was incubated with 3.8 pM-cholera toxin (0.33 mg/ml) at 37 "c for 4 h in 0.1 M-N-ethylmorphiline-HCl, 0.001 M-MgCl,, pH 8.4, with or without 2 M-urea. The reaction was stopped by a 250-fold dilution of the sample in 0.2 M-ammonium formate pH 4.5, containing 0-2 % (w/v) gelatin. The solution was immediately divided into small portions which were stored at -70 "C. Three controls were prepared for each test: (i) a portion of the enzyme and toxin mixture taken at zero time, (ii) the enzyme, and (iii) the toxin incubated separately under the same conditions as the test sample.
Toxicity assay. The toxic activities of the toxin derivatives and of their control preparations were determined by testing multiple concentrations with the rabbit intradermal assay (Craig, 1965) . To minimize errors due to the different sensitivities of individual rabbits, treated and control toxin were always compared in the same animal. The concentration required for a blueing reaction 7 mm in diameter (one blueing dose) was calculated for each preparation and the effect on toxicity of each chemical treatment expressed as the ratio of control to test values. A ratio of 1.0 meant no effect and a ratio of 0.0 a complete abolition of toxicity .
Combined assay of GMl-and antibody-binding. The G, , sorbent immunoassay technique (Holmgren, 1973) measures the in vitro binding capacity of cholera toxin to polystyreneattached G, , ganglioside, combined with the ability of the bound toxin to bind subsequently added specific antibody; the principal steps are shown in Fig. I preparation which would give a half-maximal extinction change was calculated. The extinction value for the treated preparation at this concentration was transposed to the control preparation curve, see Fig. 2(a) . Ct is the concentration of untreated toxin that gives the same extinction value as treated toxin at concentration C,. The relative GHl +antibodybinding activity of the treated preparation is expressed by the ratio Ct/Co, where a ratio of 1.0 means no effect by the modification procedure and 0.0 a complete abolition of one or both of the properties tested.
Assay of G,,-binding. G,,-binding was measured with a G,,-sorbent radioassay, in which unlabelled treated toxin competed with 1261-toxin for binding to solid-phase G,, ganglioside ( Fig. I b) . As described for the G,,-sorbent immunoassay, but with a 0.2 ml volume, the G, , ganglioside was coated to the inside of plastic tubes and the non-bound fraction washed 268
away with PBS containing 0.05 % Tween 20 (PBS-Tween). In a total volume of 0.2 ml, treated toxin in various amounts was added followed by 10 pl of a fixed amount (3.002 pg) of 1251-to~in. The tubes were incubated at 23 "C for 2 h in a roller drum, washed 3 x 3 min with PBS -Tween and tested for radioactivity in a gamma scintillator (Packard Instrument Corp.). The values for percentage of bound radioactivity were plotted against total toxin concentration. The curve intercepts with the background level were used to indicate the concentration of control (Co) or test toxin preparations (Ct) required for saturation of the G,, receptors (Fig. 2b) . The relative G,,-binding activity of the test protein is expressed as the ratio Co/Ct, where 1.0 means unchanged activity as compared with the control preparation and 0-0 means no activity.
Assay of antibody-binding. An inhibition technique was used. Mixtures of different concentrations of treated or control toxin preparation and a specific dilution of antitoxin antiserum in PBS -Tween were incubated in a total volume of 0.5 ml, at 4 "C overnight in glass tubes. These mixtures (absorbed antiserum) were transferred to plastic tubes which had been coated with toxin ( Fig. I c) , and the tubes incubated in a roller drum at 23 "C for 5 h (Holmgren & Svennerholm, 1973) . This allowed binding of the antitoxin antibodies to the solid-phase toxin, unless the combining sites of the antibodies had already been occupied by the toxin during the preincubation. After washing the tubes with PBS-Tween, bound antibodies were measured by reacting them, first with enzyme-conjugated anti-IgG and then, after washing, with substrate for the enzyme in the same manner as in the G,,-sorbent immunoassay. Extinction values were plotted against concentration of treated and control toxin preparation and the inhibitory concentrations Co and Ct were derived as shown in Fig. 2 (c) and described for the G,,-sorbent immunoassay. The relative antibody-binding activity of treated as compared with control toxin preparation is given as the ratio Ct/Co where I ' 0 means intact and 0.0 abolished activity.
Electrophoresis in polyacryldmide. Two types of electrophoresis in polyacrylamide gel were used: conventional (p.g.e.) and with added sodium dodecyl sulphate, SDS (SDS-p.g.e.). Our p.g.e. method was similar to that of Finkelstein, Fujita & Lo Spalluto (1971) except that we used flat beds (plates), and pre-electrophoresis was performed for 2 h before application of the samples. The SDS-p.g.e. technique in flat beds has been described previously . Before SDS-p.g.e., the proteins were incubated with 2% SDS, 8 M-Urea and 0.04 M-iodoacetamide at 53,"C for 15 min.
R E S U L T S
Sensitivity and dccurdcy of methods
The rabbit skin test is an established quantitative assay of cholera toxin activity (Craig, 1965) . The overall mean concentration of unmodified toxin required for I blueing dose was 0.002 pg/ml. In the three in vitro methods for measuring the receptor-binding and/or the antigenic properties of cholera toxin or toxin derivatives, the mean concentrations of unmodified toxin giving the indicated activity were 0.044 pg/ml for the combined Gm + antibody-binding immunoassay, 0.80 pg/ml for the GM1-binding radioassay, and 0-I 8 pg/ml for the antibody-fixation immuno-inhibition assay.
The variation in the determinations of relative activity was less than I-2-fold for the Gml+antibody-binding activity and less than 15-fold for the other activites (P < 0.05).
Over twenty of the toxin derivatives were prepared more than once and their relative activities were all within the experimental limits of the test methods, indicating a high degree of reproducibility.
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Modijication of cholera toxin 269 The activities of the various control toxin preparations were compared with those of purified toxin diluted directly in TG buffer. Of the buffers employed to modify the protein, only the 0.04 M-sodium hydroxide used for I ,a-cyclohexanedione and phenanthrenequinone had by itself any effect on the toxin's reactivity in the various tests (see Table 2F ).
Chemical inodification of cholera toxin
Amino-group specijic reagents. Reagents which modify amino groups in proteins do so by attaching covalently to free amino groups of lysine and to the N-terminal amino acid(s). Different concentrations of picrylsulphonic acid caused a concomitant reduction of toxicity and G,,-binding activity of cholera toxin, whereas the antibody-fixing activity was slightly more resistant (Table 2A and Fig. 2) . Succinic anhydride and, to a lesser extent, S-methylisothiourea, had similar effects (Table 2A) .
Cysteine and cystine residue speciJic reagents. Toxin was treated with chemicals that react with free sulphhydryl groups on cysteine or with cystine disulphide bridges (Table 2B) . N-ethylmaleimide and iodoacetamide, which both attach covalently to free sulphhydryl groups, did not affect any of the measured properties of the toxin. In contrast, the disulphide bridge splitting reagent 2-mercaptoethanol (alone or with iodoacetamide) decreased the toxic activity, and at higher concentrations destroyed it completely, without changing the GM1and antibody-binding properties to the same extent.
Arginyl spec@ reagents. Treatment of toxin with arginyl specific reagents had differential Modijkation of cholera toxin effects on the properties measured (Table 2C ). Phenylglyoxal and glyoxal had no effect, whereas the other three reagents used that also contained a diketene structure inhibited the toxicity without decreasing other properties concomitantly. The most divergent effects were caused by I ,a-cyclohexanedione, which inhibited toxicity but enhanced the toxin's reactivity in the combined G,,+antibody-binding assay. The latter effect may have been due to an elevated anti body-fixing capacity with the G,,-binding ability remaining unchanged ( Table  2 C ). Enhanced antibody-binding ability was seen after treatment with several reagents of various specificities. 2,3-Butanedione (I mM) produced the most pronounced differences between the GM1-binding and the antibody-fixing properties of the toxin : the former property was not affected whereas the immunological reactivity was decreased. Phenanthrenequinone was the most potent detoxifying reagent of all, but affected the GMl-and antibody-binding qualities only at high concentration.
Reagents reacting with aromatic amino acids. Toxin was treated with reagents which are more or less specific for aromatic amino acids (Table 2 D). The tryptophan-specific chemicals 2-hydroxy-5-nitrobenzyl bromide and 2-methoxy-5-nitrobenzyl bromide, also named Koshland's reagents I and 2, decreased neither toxicity nor the G,,+ antibody-binding properties of the toxin. Acetylimidazole which is a tyrosine-specific reagent, 5-amino-I -Htetrazole which modifies tyrosine and histidine, and tetranitromethane which binds to tyrosine and cysteine residues behaved similarly. The latter reagent was repeatedly found to potentiate both the toxicity and the G,, + antibody-binding capacity. Bromosuccinimide (reactive with tryptophan > tyrosine > histidine at pH 6.0) and 4-diazobenzenesulphonic acid (reactive with tyrosine and histidine) destroyed both the toxicity and the GMl+ antibody-binding capacity.
Other group-spec@ reagents. Toxin derivatives were prepared by treatment with a variety of reagents with different specificities ( Table 2 E ). Carbodiimides alter, specifically, amino acids containing a free carboxyl group, i.e. glutamic and aspartic acid and the carboxyterminal amino acid. Ethyl-3,3-dimethyl-aminopropylcarbodiimide, which was tested with and without glycine-0-methyl ester, did not affect either the toxicity or the G,, + antibodybinding capacity. Three bifunctional reagents were tested : glutaraldehyde and I ,s-difluoro-2,4-dinitrobenzene, both of which decreased the toxic, G M 1 -and antibody-binding activities, and 4,4-difluoro-3,3-dinitrodiphenylsulphone which had no effect on any of these properties. Diisopropylfluorophosphate is a widely used serine esterase inhibitor in enzymology; it has a reported specificity for the serine group responsible for esterase activity, but at higher concentration it also has an affinity for tyrosine and glutamine residues (Cohen, Oosterbaan & Berends, I 967). Only at these higher concentrations ( I o mM) of diisopropylfluorophosphate was there any effect on the cholera toxin; toxicity was abolished, together with GM1and antibody-binding capacities. This indicates that the toxin itself does not act as a serine esterase, since the toxic activity then would probably have been much more labile than the two other properties.
Other types of reagents. The toxin was treated with two exopeptidases, leucine aminopeptidase and carboxypeptidase A, which digest protein from the amino and carboxy terminal ends respectively, and with the endopeptidase trypsin (Table 2F ). None of these enzymes had any influence, even at high concentrations, on the toxic or the Gylor antibodyfixing activities of the toxin when tested in ordinary buffer. However, in the presence of 2 M-Urea both carboxypeptidase A and trypsin abolished toxicity without affecting G,and antibody-fixing properties.
Sodium hydroxide (0.04 to I M) also inhibited both toxicity and G, , + antibody-binding capacity. When G,,-binding and antibody-fixation were tested separately it appeared that the most pronounced effect was on antigenicity. With 0.01 M-sodium hydroxide a selective increase of G,,-binding capacity of the toxin was produced. Sodium dodecylsulphate has previously been used for disaggregation of the toxin into its subunits . It abolished toxicity but had little effect on the GMland antibody-binding activities of the toxin.
Behaviour of modified toxin in polyacrylarnide electrophoresis SDS-p.g.e. separates the non-covalently linked subunits of cholera toxin into two protein bands representing the fast-migrating L subunit, molecular weight about 8000, and the slower-moving H subunit, molecular weight 28 000 (Lonnroth & Holmgren, I 973) . Any change in migration speed after treatment would imply that covalent bonds had been generated or broken between or in the peptides. In p.g.e. the toxin migrates as a single band with a relatively slow mobility. Separated H subunit and L subunit complexes, corresponding to choleragenoid, migrate faster and slower, respectively, than the intact toxin (unpublished). A changed banding pattern in p.g.e. after treatment would suggest a change in aggregation state and/or in the net charge of the toxin.
A number of toxin derivatives were examined both by electrophoresis and in the toxicity assay, to test whether effects on toxic activity induced by the chemical treatment were due to changes in the aggregation state of the toxin. The effect of SDS modification on toxicity was paralleled by a changed migration in p.g.e.; the single band of untreated toxin was replaced by a faster-moving component probably representing H subunit negatively charged by the SDS groups, and a slower material which:migrated like aggregated L subunit (Fig. 3) 2-Mercaptoethanol also changed toxicity and the behaviour in p.g.e. concomitantly (Table 3) . A similar pattern as described for SDS-treated derivatives was 'seen except that the fastmoving component, devoid of the negative SDS-groups, had the same migration rate as isolated H subunit, and the slower component showed more tailing (Fig. 3) . In SDS-p.g.e. the effect was visible only at higher concentrations of 2-mercaptoethanol than those which IP: 54.70.40.11
Modijication of cholera toxin 273 Table 3 . Efect of modijication on cholera toxin studied by polyacrylamide gel electrophoresis with and without S D S diminished the toxicity. At these higher concentrations a split of the H subunit into probable half-molecules takes place . Bromosuccinimide (1 mM, pH 6.0), which has been reported to cleave peptides at acid pH (Ramachandran & Witkop, 1967) , had no visible effect on the behaviour of the toxin in any of the electrophoretic tests, despite a total inhibitory influence on all the functional properties studied (Table 3) . 1,2-Cyclohexanedione (I mM) also did not affect the electrophoretic patterns, although differential effects were seen on toxicity and G,, +antibodybinding. Increasing concentrations of picrylsulphonic acid progressively increased the mobility of the toxin in p.g.e., which probably was due to electroneutralization of positively charged lysine groups (Fig. 3) . The aggregation state of toxin treated with this reagent seemed unaffected in the p.g.e. analyses; in SDS-p.g.e. the proportion of L and H subunit material was unchanged but the L subunit had a slower mobility than usual. At high concentration, phenanthrenequinone had an effect similar to that of 2-mercaptoethanol in SDS-p.g.e., i.e. it cleaved the H subunit, but it also abolished toxicity at lower concentrations, which had no effect on the behaviour of the toxin in either p.g.e. or SDS-p.g.e.
Modij?cation of V. cholerae culture Jiltrate
Preliminary studies with V. cholerae culture filtrate showed that the in vitro assays of the G,, receptor-binding and the antibody-fixing properties of purified toxin could be used with similar accuracy for evaluating the crude material (Holmgren, 1973 ; Holmgren & Svennerholm, 1973) . Although dialysed and concentrated V. cholerae culture filtrate contained large amounts of other bacterial proteins, after treatment with four reagents (N-ethylmaleimide, phenylglyoxal, picrylsulphonic acid and I ,a-cyclohexanedione, all at I o mM) which had different residue specificity and different effects on the tested properties of purified cholera toxin, the derivatives gave the same results as those produced with treated purified toxin.
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DISCUSSION
The techniques described here, which can be applied to small quantities of purified or crude toxin preparations, may be useful for comparative studies between cholera toxin and other bacterial enterotoxins. Some of the treatments decreased the ability of cholera toxin to bind in vitro to the ganglioside G, , and caused a concomitant reduction in toxicity. These effects were not unexpected, since recent studies strongly indicate that the G, , ganglioside functions as membrane receptor for the toxin in'various target cells King & van Heyningen, 1973 ; Cuatrecasas, 1973 b ; . The toxicity, however, was also destroyed by a few reagents which had no influence on the GM,-binding ability. This supports the previous finding that structures which are not involved in cellbinding are required for the expression of toxic activity. The H subunit of cholera toxin is needed for toxic activity but is not binding either to G,, ganglioside in vitro or to target cells Cuatrecasas et al. 1973; Holmgren et al. 1974; van Heyningen, 1974; . It seems likely, therefore, that those reagents which had a selective effect on the toxic activity affected principally the H subunit in a manner which prevented it inducing the presumed key event in the toxic action, i.e. activation of membrane adenylate cyclase. The decrease in toxicity caused by reagents such as 2-mercaptoethanol and SDS illustrates the importance of assembled subunits for biological activity . Two of the other three reagents which selectively destroyed the toxicity did not, at the concentrations used, affect the quaternary structure of the toxin as studied by gel electrophoresis. This suggests that the loss in biological activity of the toxin was caused by a critical modification in situ of the H subunit. Holmgren et al. (I 974) and found that all of the receptor-binding as well as most of the antigenic properties of the toxin reside in the same type of subunit. This finding is supported by the present results from the separate testing of G,,-binding and antibody-fixation of toxin derivatives. Most reagents had a concomitant effect on these properties, indicating a close structural association between the receptor-binding and the antigenic sites. A few reagents however, like 2-mercaptoethanol ( IOO mM), picrylsulphonic acid (I mM) or a~-butanedione (I mM), affected these properties differently.
This information on the gross relationships between the toxic, receptor-binding and antigenic sites of cholera toxin, is supplemented by information on the type of residues contributing to the structural arrangement of these sites. However, such interpretations are preliminary, since with the limited amounts of toxin available it has not been possible to . assess the efficiency of the chemical treatments in terms of specificity and extent of residue modification. Amino group reagents such as picrylsulphonic acid, succinic anhydride, S-methylisothiourea, glutaraldehyde, and r,5-difluoro-2,4 dinitrobenzene destroyed the properties of toxicity and receptor + antibody-binding concomitantly. Since leucine aminopeptidase, which digests proteins from the amino terminal end, did not affect any of these features of the toxin, with or without urea, even at high concentration, it is probably the modification of lysine groups which is responsible for the observed changes in toxin properties induced by amino group reagents. The GN1-binding quality seemed to be more sensitive than the antibody-binding capacity, which suggests that lysine groups are involved in the binding of toxin to the acidic G M 1 ganglioside receptor. This interpretation is consistent with data on the amino acid composition of cholera toxin, and on a ' natural ' cholera toxoid, choleragenoid (Finkelstein, 1973) . The latter protein has the same composition as the toxin except for 1acking:the 'toxic' H subunit . Therefore, the reported finding that choleragenoid contains 80 % of the lysine residues of the toxin demon-On: Thu, 06 Dec 2018 08:18:45 Modij?cation of cholera toxin 275 strates that lysine residues are particularly frequent in the receptor-binding L subunit aggregate portion of the toxin. Three types of toxin derivatives prepared by reagents which are specific for arginine lost toxicity but retained intact GMl-and antibody-binding qualities. Since arginine is much more abundant in the toxin than in choleragenoid (Finkelstein, 1973) , i.e. it is present predominantly in the 'toxic' subunit H, and since tests with two of our derivatives showed that the chemical modification had not changed the aggregation state of the toxin, we believe that arginine residues of the toxin may be involved in the 'toxic site ' inducing activation of target cell adenylate cyclase.
Reagents with the same reported specificity sometimes had quite different effects on cholera toxin. Variation in reactivity of a functional group is a common observation in protein modification studies, and is usually explained by differences in accessibility of the functional groups to the reagents (Cohen, 1968) . Altered accessibility of the site of proteolysis could also explain the observed difference in effect of the two proteolytic enzymes trypsin and carboxypeptidase A in the presence and absence of urea.
Cholera is the prototype for the acute bacterial diarrhoea1 diseases named enterotoxic enteropathies (Craig, I 972). The techniques described here, which require only small quantities of toxin, may be useful for comparative studies between cholera toxin and other bacterial enterotoxins. Toxoids for immunoprophylaxis against these diseases are urgently required (Feeley, 1974) . A formalinized cholera toxoid was tested but was unsuitable due to reversion to toxicity (Northrup & Chisari, I 972), and glutaraldehyde treatment reduced antigenicity as well as toxicity (Rappaport et al. 1974) . The present study has indicated that selective chemical treatments of cholera toxin supported by sensitive methods of detecting the biological results of such treatments might be useful in the search for efficacious toxoid preparations.
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